wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46163359-81CDCC15-93B9-442C-8153-44DF7673FF75
Q46163359-81CDCC15-93B9-442C-8153-44DF7673FF75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46163359-81CDCC15-93B9-442C-8153-44DF7673FF75
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.
P2860
Q46163359-81CDCC15-93B9-442C-8153-44DF7673FF75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46163359-81CDCC15-93B9-442C-8153-44DF7673FF75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39b3a6b51a5223a3d6c71b4ffa634e90d83738b2
P2860
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.